Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aptus PharmaBOM:544529 +3.34%18 Operating Margin % is 13.19% as of Mar. 2026, which is 17% above its 10-year median of 11.29. GuruFocus rates BOM:544529 with a GF Score™ of 18/100. The stock has 6 warning signs investors should review. Among 119 Medical Distribution companies, Aptus Pharma ranks better than 96.64% on this metric.
Operating Margin % is calculated as Operating Income divided by its Revenue. Aptus Pharma's Operating Income for the
six
months ended in Mar. 2026 was ₹42.5 Mil. Aptus Pharma's Revenue for the
six
months ended in Mar. 2026 was ₹322.0 Mil. Therefore, Aptus Pharma's Operating Margin % for the quarter that ended in Mar. 2026 was 13.19%.
The historical rank and industry rank for Aptus Pharma's Operating Margin % or its related term are showing as below:
BOM:544529'
s Operating Margin % Range Over the Past 10 Years
Min: 3.15 Med: 11.29 Max: 18.66
Current: 15.11
BOM:544529's Operating Margin % is ranked better than 96.64% of 119
companies
in the Medical Distribution industry
Industry Median: 2.97
vs BOM:544529: 15.11
Aptus Pharma's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.
Aptus Pharma's Operating Income for the
six
months ended in Mar. 2026 was ₹42.5 Mil.
Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was ₹70.4 Mil.
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Aptus Pharma Operating Margin % Related Terms
Aptus Pharma Operating Margin % Historical Data
* Premium members only.
The historical data trend for Aptus Pharma's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:544529 vs MCK, COR, CAH: Operating Margin % Comparison
For the Medical Distribution subindustry, Aptus Pharma's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aptus Pharma Operating Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Aptus Pharma's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Aptus Pharma's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Aptus Pharma's Operating Margin % for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aptus Pharma (BOM:544529) has a Operating Margin % of 13.19% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Aptus Pharma and its competitors. This is 17% above median its historical median of 11.29. Over the past decade, Aptus Pharma's Operating Margin % has ranged from 3.15 to 18.66. According to the industry distribution chart, Aptus Pharma ranks #4 out of 119 companies in the Medical Distribution industry, placing it in the top 3.4%.
Is Aptus Pharma's Operating Margin % too high?
Aptus Pharma's current Operating Margin % of 13.19% is 17% above median its 10-year median of 11.29. Over the past 10 years, this metric has ranged from a low of 3.15 to a high of 18.66. The Medical Distribution industry median Operating Margin % is 2.97. Aptus Pharma's value of 13.19% is 344.1% above this industry median. Based on the distribution chart, Aptus Pharma ranks #4 out of 119 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Aptus Pharma has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Aptus Pharma's Operating Margin % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Aptus Pharma ranks #4 out of 119 companies for Operating Margin %. This places Aptus Pharma in the top 3% of its industry — outperforming the majority of peers. The industry median Operating Margin % is 2.97. Aptus Pharma's value of 13.19% is 344.1% above this benchmark. Historically, Aptus Pharma's own Operating Margin % has ranged from 3.15 to 18.66 over the past decade. While the company's 10-year median is 11.29 vs. the industry median of 2.97, Aptus Pharma has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Distribution company?
The median Operating Margin % among Medical Distribution companies is 2.97, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aptus Pharma's current Operating Margin % of 13.19% is 344.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Aptus Pharma and its competitors. For the Medical Distribution industry, the median Operating Margin % is 2.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aptus Pharma's current Operating Margin % is 13.19%, which is 17% above median its own 10-year median of 11.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aptus Pharma stock overvalued right now?
Aptus Pharma (BOM:544529) has a current Operating Margin % of 13.19%. The current Operating Margin % is 13.19%, which is 17% above median its 10-year median of 11.29 and 344.1% above the Medical Distribution industry median of 2.97. Aptus Pharma's overall GF Score™ is 18/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Aptus Pharma (BOM:544529), the current Operating Margin % is 13.19% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Aptus Pharma Ltd is engaged in the business of marketing and distribution of finished pharmaceutical formulations. It operates through a contract manufacturing model. The group provides a diverse range of pharmaceutical products catering to various therapeutic categories, including anti-infectives, gastrointestinal, antacids, anti-allergic and respiratory, nutritional supplements, pain management, neuro-psychiatric, cardiovascular, anti-diabetic, lipid-lowering, and general wellness products. These are offered across a variety of dosage forms, such as tablets, capsules, softgels, syrups, suspensions, injections, ointments, creams, balms, drops, lotions, vials, powders, gels, and sachets.
18GF Score
Get the complete analysis for BOM:544529
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544529 has been successfully added to your 
